Home › Non-Hodgkin Lymphoma › NCT00626496
Family Study of Lymphoproliferative Disorders
Genetic Epidemiology of Lymphoproliferative Disorders
Who can join
Ages 18 to 100 · All sexes · Healthy volunteers welcome
Full eligibility criteria
At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
About the study
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
Sponsor: Mayo Clinic · Participants: 3,000 · Started: Apr 1, 2004
Contact the study team
- Catie Erding · Phone: 1-855-899-0693
Official record on ClinicalTrials.gov — NCT00626496
Locations in the U.S.
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.